Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin

Background This study evaluated health-related quality of life (HRQOL) using patient-reported outcomes in subjects with mucinous appendiceal neoplasms who underwent cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as part of a randomized trial comparing mitomycin wi...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of surgical oncology Vol. 27; no. 3; pp. 772 - 780
Main Authors:	Moaven, Omeed, Votanopoulos, Konstantinos I., Shen, Perry, Mansfield, Paul, Bartlett, David L., Russell, Greg, McQuellon, Richard, Stewart, John H., Levine, Edward A.
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01.03.2020 Springer Nature B.V
Subjects:	Adenocarcinoma, Mucinous - secondary Adenocarcinoma, Mucinous - therapy Adult Aged Aged, 80 and over Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Appendiceal Neoplasms - pathology Appendiceal Neoplasms - therapy Appendix Cancer Chemotherapy Combined Modality Therapy Cytoreduction Surgical Procedures Female Gastrointestinal cancer Health Status Humans Hyperthermia, Induced Male Medicine Medicine & Public Health Middle Aged Mitomycin Mitomycin - adverse effects Mitomycin - therapeutic use Neurotoxicity Oncology Oxaliplatin Oxaliplatin - adverse effects Oxaliplatin - therapeutic use Patient Reported Outcome Measures Perfusion Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Peritoneal Surface Malignancy Peritoneum Prospective Studies Quality of Life Questionnaires Surgery Surgical Oncology Survival Survival Rate Well being Young Adult
ISSN:	1068-9265, 1534-4681, 1534-4681
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!